Chronobiology of Arterial Hypertension in Hemodialysis Patients: Implications for Home Blood Pressure Monitoring

Rajiv Agarwal, Robert P. Light

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: Hemodialysis patients have a steady increase in blood pressure (BP) during the 44-hour interdialytic interval when ambulatory BP monitoring is used. Home BP recording allows for a longer period of monitoring between dialysis treatments and may better define the chronobiological characteristics of arterial hypertension. This study sought to determine the optimal time to perform home BP monitoring in hemodialysis patients to improve the strength of prediction of 44-hour interdialytic ambulatory BP. Study Design: Diagnostic test study. Setting & Participants: This is an ancillary analysis of patients participating in the Dry-weight Reduction in Hypertensive Hemodialysis Patients (DRIP) trial. Index Test: Home BP measured 3 times daily for 1 week by using a validated oscillometric monitor on 3 occasions at 4-week intervals after randomization. Home BP measured during the first third, second third, and last third of time elapsed after the dialysis treatment, as well as each third of the dialysis treatment, was compared with the overall ambulatory BP. Reference Tests: Interdialytic ambulatory BP measured on 3 occasions at 4-week intervals after randomization. Results: During the interdialytic interval, we found an increase in systolic ambulatory BP of 0.30 ± 0.36 mm Hg/h and an increase in systolic home BP of 0.40 ± 0.25 mm Hg/h. This relationship in home BP reached a plateau after approximately 48 hours. A similar pattern was seen for diastolic home BP. Probing dry weight steepened the slope of ambulatory BP, but did not alter the time-dependent relationship of home BP. Home BP was on average higher (bias) by 14.1 (95% confidence interval, 12.0 to 16.2)/5.7 mm Hg (95% confidence interval, 4.6 to 6.9). The SD of differences between methods (precision) was 4.6/2.8 mm Hg. Measurement of BP during each third of the interdialytic interval gave the best precision, measured by using model fit compared with ambulatory BP measurements. Limitations: Our cohort was overrepresented by African American hemodialysis patients. Whether African American participants have a different pattern of BP response than non-African American participants in the interdialytic period is not known. Conclusions: Our findings suggest that time elapsed after a dialysis treatment must be considered in interpreting home BP recordings in hemodialysis patients. Home BP measured in each third of the interdialytic interval is likely to yield the most reliable BP estimate.

Original languageEnglish (US)
Pages (from-to)693-701
Number of pages9
JournalAmerican Journal of Kidney Diseases
Volume54
Issue number4
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Ambulatory Blood Pressure Monitoring
Renal Dialysis
Blood Pressure
Hypertension
Dialysis
Random Allocation
African Americans
Confidence Intervals

Keywords

  • ambulatory blood pressure (BP) monitoring
  • chronobiology
  • hemodialysis
  • Home blood pressure (BP)
  • hypertension

ASJC Scopus subject areas

  • Nephrology

Cite this

Chronobiology of Arterial Hypertension in Hemodialysis Patients : Implications for Home Blood Pressure Monitoring. / Agarwal, Rajiv; Light, Robert P.

In: American Journal of Kidney Diseases, Vol. 54, No. 4, 10.2009, p. 693-701.

Research output: Contribution to journalArticle

@article{33f27d338cf14c1b84aa262afffc9a7c,
title = "Chronobiology of Arterial Hypertension in Hemodialysis Patients: Implications for Home Blood Pressure Monitoring",
abstract = "Background: Hemodialysis patients have a steady increase in blood pressure (BP) during the 44-hour interdialytic interval when ambulatory BP monitoring is used. Home BP recording allows for a longer period of monitoring between dialysis treatments and may better define the chronobiological characteristics of arterial hypertension. This study sought to determine the optimal time to perform home BP monitoring in hemodialysis patients to improve the strength of prediction of 44-hour interdialytic ambulatory BP. Study Design: Diagnostic test study. Setting & Participants: This is an ancillary analysis of patients participating in the Dry-weight Reduction in Hypertensive Hemodialysis Patients (DRIP) trial. Index Test: Home BP measured 3 times daily for 1 week by using a validated oscillometric monitor on 3 occasions at 4-week intervals after randomization. Home BP measured during the first third, second third, and last third of time elapsed after the dialysis treatment, as well as each third of the dialysis treatment, was compared with the overall ambulatory BP. Reference Tests: Interdialytic ambulatory BP measured on 3 occasions at 4-week intervals after randomization. Results: During the interdialytic interval, we found an increase in systolic ambulatory BP of 0.30 ± 0.36 mm Hg/h and an increase in systolic home BP of 0.40 ± 0.25 mm Hg/h. This relationship in home BP reached a plateau after approximately 48 hours. A similar pattern was seen for diastolic home BP. Probing dry weight steepened the slope of ambulatory BP, but did not alter the time-dependent relationship of home BP. Home BP was on average higher (bias) by 14.1 (95{\%} confidence interval, 12.0 to 16.2)/5.7 mm Hg (95{\%} confidence interval, 4.6 to 6.9). The SD of differences between methods (precision) was 4.6/2.8 mm Hg. Measurement of BP during each third of the interdialytic interval gave the best precision, measured by using model fit compared with ambulatory BP measurements. Limitations: Our cohort was overrepresented by African American hemodialysis patients. Whether African American participants have a different pattern of BP response than non-African American participants in the interdialytic period is not known. Conclusions: Our findings suggest that time elapsed after a dialysis treatment must be considered in interpreting home BP recordings in hemodialysis patients. Home BP measured in each third of the interdialytic interval is likely to yield the most reliable BP estimate.",
keywords = "ambulatory blood pressure (BP) monitoring, chronobiology, hemodialysis, Home blood pressure (BP), hypertension",
author = "Rajiv Agarwal and Light, {Robert P.}",
year = "2009",
month = "10",
doi = "10.1053/j.ajkd.2009.03.018",
language = "English (US)",
volume = "54",
pages = "693--701",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Chronobiology of Arterial Hypertension in Hemodialysis Patients

T2 - Implications for Home Blood Pressure Monitoring

AU - Agarwal, Rajiv

AU - Light, Robert P.

PY - 2009/10

Y1 - 2009/10

N2 - Background: Hemodialysis patients have a steady increase in blood pressure (BP) during the 44-hour interdialytic interval when ambulatory BP monitoring is used. Home BP recording allows for a longer period of monitoring between dialysis treatments and may better define the chronobiological characteristics of arterial hypertension. This study sought to determine the optimal time to perform home BP monitoring in hemodialysis patients to improve the strength of prediction of 44-hour interdialytic ambulatory BP. Study Design: Diagnostic test study. Setting & Participants: This is an ancillary analysis of patients participating in the Dry-weight Reduction in Hypertensive Hemodialysis Patients (DRIP) trial. Index Test: Home BP measured 3 times daily for 1 week by using a validated oscillometric monitor on 3 occasions at 4-week intervals after randomization. Home BP measured during the first third, second third, and last third of time elapsed after the dialysis treatment, as well as each third of the dialysis treatment, was compared with the overall ambulatory BP. Reference Tests: Interdialytic ambulatory BP measured on 3 occasions at 4-week intervals after randomization. Results: During the interdialytic interval, we found an increase in systolic ambulatory BP of 0.30 ± 0.36 mm Hg/h and an increase in systolic home BP of 0.40 ± 0.25 mm Hg/h. This relationship in home BP reached a plateau after approximately 48 hours. A similar pattern was seen for diastolic home BP. Probing dry weight steepened the slope of ambulatory BP, but did not alter the time-dependent relationship of home BP. Home BP was on average higher (bias) by 14.1 (95% confidence interval, 12.0 to 16.2)/5.7 mm Hg (95% confidence interval, 4.6 to 6.9). The SD of differences between methods (precision) was 4.6/2.8 mm Hg. Measurement of BP during each third of the interdialytic interval gave the best precision, measured by using model fit compared with ambulatory BP measurements. Limitations: Our cohort was overrepresented by African American hemodialysis patients. Whether African American participants have a different pattern of BP response than non-African American participants in the interdialytic period is not known. Conclusions: Our findings suggest that time elapsed after a dialysis treatment must be considered in interpreting home BP recordings in hemodialysis patients. Home BP measured in each third of the interdialytic interval is likely to yield the most reliable BP estimate.

AB - Background: Hemodialysis patients have a steady increase in blood pressure (BP) during the 44-hour interdialytic interval when ambulatory BP monitoring is used. Home BP recording allows for a longer period of monitoring between dialysis treatments and may better define the chronobiological characteristics of arterial hypertension. This study sought to determine the optimal time to perform home BP monitoring in hemodialysis patients to improve the strength of prediction of 44-hour interdialytic ambulatory BP. Study Design: Diagnostic test study. Setting & Participants: This is an ancillary analysis of patients participating in the Dry-weight Reduction in Hypertensive Hemodialysis Patients (DRIP) trial. Index Test: Home BP measured 3 times daily for 1 week by using a validated oscillometric monitor on 3 occasions at 4-week intervals after randomization. Home BP measured during the first third, second third, and last third of time elapsed after the dialysis treatment, as well as each third of the dialysis treatment, was compared with the overall ambulatory BP. Reference Tests: Interdialytic ambulatory BP measured on 3 occasions at 4-week intervals after randomization. Results: During the interdialytic interval, we found an increase in systolic ambulatory BP of 0.30 ± 0.36 mm Hg/h and an increase in systolic home BP of 0.40 ± 0.25 mm Hg/h. This relationship in home BP reached a plateau after approximately 48 hours. A similar pattern was seen for diastolic home BP. Probing dry weight steepened the slope of ambulatory BP, but did not alter the time-dependent relationship of home BP. Home BP was on average higher (bias) by 14.1 (95% confidence interval, 12.0 to 16.2)/5.7 mm Hg (95% confidence interval, 4.6 to 6.9). The SD of differences between methods (precision) was 4.6/2.8 mm Hg. Measurement of BP during each third of the interdialytic interval gave the best precision, measured by using model fit compared with ambulatory BP measurements. Limitations: Our cohort was overrepresented by African American hemodialysis patients. Whether African American participants have a different pattern of BP response than non-African American participants in the interdialytic period is not known. Conclusions: Our findings suggest that time elapsed after a dialysis treatment must be considered in interpreting home BP recordings in hemodialysis patients. Home BP measured in each third of the interdialytic interval is likely to yield the most reliable BP estimate.

KW - ambulatory blood pressure (BP) monitoring

KW - chronobiology

KW - hemodialysis

KW - Home blood pressure (BP)

KW - hypertension

UR - http://www.scopus.com/inward/record.url?scp=70349243233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349243233&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2009.03.018

DO - 10.1053/j.ajkd.2009.03.018

M3 - Article

C2 - 19515473

AN - SCOPUS:70349243233

VL - 54

SP - 693

EP - 701

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -